YI, US68247Q2012

111 forms special committee: what it means for 111 stock

Published on 10/02/2026 at 02:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

A USD 4.52 per ADS proposal targets 111 stock. Second-quarter 2026 revenue fell 28.30 percent to RMB 2.3 billion from RMB 3.2 billion.

YI, US68247Q2012, Illustration mit AI erstellt.

111, Inc. (ISIN US68247Q2012) formed a special committee on September 28, 2026 to review a preliminary buyout proposal and other strategic alternatives, according to PR Newswire. The development gives 111 stock a defined transaction reference, but the proposal remains preliminary and non-binding.

Special committee reviews USD 4.52 proposal

The committee has three independent directors, with Jian Sun as chair and Nee Chuan Teo and Jun Luo as members. The board is evaluating the proposal dated September 16, 2026 alongside other alternatives, according to PR Newswire.

The buyer group, comprising co-founders Gang Yu and Junling Liu and Huadeng Tech BioArray Ventures, proposed USD 0.226 per Class A share, equivalent to USD 4.52 per ADS. Fidelity reported that the proposed transaction would cover Class A shares not already owned by the buyer group.

Revenue falls as strategy shifts

111 reported second-quarter 2026 net revenue of RMB 2.3 billion, down 28.30 percent from RMB 3.2 billion in the prior-year quarter, in the results released by PR Newswire. The company linked the decline to its shift from an asset-heavy model toward a more asset-light structure.

The operating mix contained a brighter counterpoint: marketplace service revenue increased 18.20 percent year over year in the first half of 2026, while promotional-products revenue rose 121.00 percent to RMB 60.7 million. The figures point to a business transition in which lower overall revenue is being weighed against higher-growth service and product niches.

Losses keep the proposal in context

Second-quarter 2026 net loss reached RMB 31.7 million, compared with RMB 7.3 million in the prior-year quarter, while gross segment profit fell 28.60 percent to RMB 132.3 million. Operating cash flow was negative RMB 11.4 million in the quarter, according to PR Newswire.

Small-cap valuation remains event driven

111 had a market capitalization of USD 28.9 million and a 52-week range of USD 2.48 to USD 11.17 as of October 1, 2026. The Nasdaq-listed healthcare platform connects consumers, pharmacies and pharmaceutical companies through online retail, wholesale and healthcare services.